Philip Morris (PM) Q4 Earnings Lag Estimates, Revenues Rise

Philip Morris (PM) Q4 Earnings Lag Estimates, Revenues Rise

Explore stocks on Coinbase

Philip Morris International Inc. PM posted fourth-quarter 2023 results, wherein the bottom line fell short of the Zacks Consensus Estimate. However, the top line increased year over year and beat the Zacks Consensus Estimate. The company continued to benefit from pricing power, along with strength in IQOS and ZYN.

The company entered 2024 on a solid note and expects it to be another strong year, backed by organic smoke-free net revenue and profit growth

Quarter in Detail

Adjusted earnings per share (EPS) came in at $1.36, which dropped 2.2% year over year. However, the bottom line fell short of the Zacks Consensus Estimate of $1.44. The bottom line increased 12.2%, excluding currency movements.

Philip Morris International Inc. Price, Consensus and EPS Surprise

Philip Morris International Inc. price-consensus-eps-surprise-chart | Philip Morris International Inc. Quote

Net revenues of $9,047 million increased 11% on a reported basis and 8.3% on an organic basis (excluding currency movements and acquisitions). The Zacks Consensus Estimate for the top line was pegged at $8,959 million. The increase in organic revenues was backed by higher pricing variance (mainly backed by elevated combustible tobacco pricing) and a positive volume/mix (accountable to increased heated tobacco unit or HTU volumes).

During the quarter, net revenues from combustible products were up 5.3% to $5,489 million (also up 5.3% on an organic basis). Revenues from smoke-free products (excluding Wellness and Healthcare) jumped 21.7% to $3,489 million (up 14.2% organically).

Net revenues from smoke-free products formed 39.3% of the company’s total revenues. Total IQOS users at the end of 2023 were estimated at roughly 28.6 million, up 3.7% year over year. This includes nearly 20.8 million who switched to IQOS and stopped smoking.

Total cigarette and HTU shipment volumes fell by 0.5% to 185.1 billion units in the quarter. HTU shipment volumes of 34 billion units rose 6.1% year over year, and Oral Products shipment volumes more than doubled to $219.6 million cans.

The adjusted operating income ascended 8% on an organic basis to $3,052 million due to improved pricing variance, somewhat negated by increased marketing, administration and research costs (stemming from inflation) as well as escalated manufacturing costs.

Region-Wise Performance

Net revenues in the European region grew 9.6% on an organic basis to $3,614 million. This was a result of favorable pricing and volume/mix. Total shipment volumes in the region increased 2.6% to 53.6 billion units.

In the SSEA, CIS & MEA regions, adjusted net revenues increased 13% organically to $2,707 million on improved pricing variance and a favorable volume/mix. Total shipment volumes rose by 0.5% to 90.5 billion units.

In the EA, AU & PMI DF regions, net revenues dipped 0.1% organically to $1,430 million due to the adverse volume/mix, mostly offset by better pricing variance. Total shipment volumes in the region tumbled 7.5% to 23.2 billion units.

Revenues in the Americas dropped 4.9% on an organic basis to $545 million. This was a result of an adverse volume/mix, partly made up by improved pricing. Shipment volumes decreased 5.1% to 17.7 billion units.